New implant for heart failure could halve hospital readmission rates

A new implantable device called CardioMEMS could significantly reduce hospital readmissions for heart failure patients, according to doctors at Cleveland Clinic Abu Dhabi. The small wireless device, implanted into the pulmonary artery, continuously monitors pressure changes that can signal early fluid build-up, often days before patients experience symptoms like shortness of breath, fatigue, and swelling.

This early warning system allows doctors to intervene sooner, potentially averting the need for hospitalization. The device was recently implanted in two Emirati patients in their 60s, marking the first such procedures in the emirate. CardioMEMS is a permanent implantation performed during a minimally invasive procedure in the catheterisation laboratory.

Patients are given an electronic pillow which they must lie on for 15 to 20 seconds daily to transmit data to the heart failure team. The team reviews these readings daily and adjusts medication doses as necessary to prevent fluid overload. Heart failure, affecting over 64 million adults worldwide, is often caused by coronary artery disease, high blood pressure, genetic conditions, or infections.

Managing the condition involves preventing repeated hospitalizations, as each admission can lead to complications such as infections, kidney injury, or liver injury. Remote monitoring with CardioMEMS enables doctors to detect changes before symptoms appear, allowing for timely adjustments to medication dosages and preventing worsening of the condition.

While the device is not suitable for all patients, it has the potential to significantly improve the quality of life for those with advanced heart failure and reduce the risk of further complications.